Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic.

Pavord, Sue; Thachil, Jecko; Hunt, Beverley J; Murphy, Mike; Lowe, Gillian; Laffan, Mike; Makris, Mike; Newland, Adrian C; Provan, Drew; Grainger, John D; Hill, Quentin A

Pavord, Sue; Thachil, Jecko; Hunt, Beverley J; Murphy, Mike; Lowe, Gillian; Laffan, Mike; Makris, Mike; Newland, Adrian C; Provan, Drew; Grainger, John D; Hill, Quentin A.

Pavord S; Department of Haematology, Oxford University Hospitals, Oxford, UK.
Thachil J; Department of Haematology, Manchester University Foundation Trust, Manchester, UK.
Hunt BJ; Department of Haematology, Guy's and St Thomas' Hospital, London, UK.
Murphy M; Department of Haematology, John Radcliffe Hospital, NHSBT, Oxford, UK.
Lowe G; Department of Haematology, University Hospitals of Birmingham, Birmingham, UK.
Laffan M; Department of Haematology, Hammersmith Hospital, Du Cane Road, UK.
Makris M; Department of Haematology, Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK.
Newland AC; Department of Haematology, Barts and the London School of Medicine and Dentistry, London, UK.
Provan D; Department of Haematology, Queen Mary University of London, Bart's and The London School of Medicine and Dentistry, Institute of Cell and Molecular Science, London, UK.
Grainger JD; Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Hill QA; Department of Haematology, St James's University Hospital, Leeds, UK.

Br J Haematol ; 189(6): 1038-1043, 2020 06.

Article in English | MEDLINE | ID: covidwho-186388

ABSTRACT

ABSTRACT

This document aims to provide practical guidance for the assessment and management of patients with thrombocytopenia, with a particular focus on immune thrombocytopenia (ITP), during the COVID-19 pandemic. The intention is to support clinicians and, although recommendations have been provided, it is not a formal guideline. Nor is there sufficient evidence base to conclude that alternative approaches to treatment are incorrect. Instead, it is a consensus written by clinicians with an interest in ITP or coagulation disorders and reviewed by members of the UK ITP forum.

Subject(s)

Betacoronavirus; Coronavirus Infections; Pandemics; Pneumonia, Viral; Purpura, Thrombocytopenic, Idiopathic; Adult; COVID-19; Coronavirus Infections/epidemiology; Coronavirus Infections/etiology; Coronavirus Infections/therapy; Female; Humans; Male; Pneumonia, Viral/epidemiology; Pneumonia, Viral/etiology; Pneumonia, Viral/therapy; Practice Guidelines as Topic; Purpura, Thrombocytopenic, Idiopathic/congenital; Purpura, Thrombocytopenic, Idiopathic/epidemiology; Purpura, Thrombocytopenic, Idiopathic/therapy; SARS-CoV-2

Keywords

ITP; TPO RA; intravenous immunoglobulin; platelets; steroids; thrombosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Purpura, Thrombocytopenic, Idiopathic / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Observational study / Prognostic study Limits: Adult / Female / Humans / Male Language: English Journal: Br J Haematol Year: 2020 Document Type: Article Affiliation country: Bjh.16775

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google